Contributor: Bernadett M. Varga

Bernadett Varga ESMH ContributorBernadett Varga is a freelance public health professional, former Scientific Collaborator of the Brussels-based Université Catholique de Louvain and co-author of a Springer publication titled Access to Primary Care and Preventative Health Services of Migrants (2018). She started her early career as a health advocate, holds a BSc degree in Communications from the University of Szeged, Hungary, studied Medicine at the Semmelweis University before earning her MSc degree in European Public Health at the University of Maastricht and holds a certificate from the Harvard Kennedy School – Executive Education. She is an expert on EU public health policies, has worked for the Council of Europe, has collaborated with the World Health Organization and the United Nations OHCHR on formulating health policy recommendations targeting vulnerable groups. Her research focuses on health disparities in Europe as well as on the access to healthcare services for disadvantaged groups, such as the Roma and migrant populations. Bernadett resides in Brussels, Belgium.

COVID-19 illustration in microscope

Prof. Wayne Koff : “AI can help us design better, safer and faster vaccines”

Wayne Koff, PhD, is the founding president and Chief Executive Officer of the Human Vaccines Project. Human Vaccines Project Prior to joining the Project, from 1999 to 2016, Koff served as Chief Scientific Officer and Senior Vice President of Research and Development at the International AIDS Vaccine Initiative (IAVI) in New York City, leading IAVI’s ...

Coronavirus mutation vector background with disease molecules on blue. Medical research or pandemic virus prevention banner with COVID-19 abstract images under microscope. Europe coronavirus mutation

A scientist’s opinion : Interview with Prof. András Falus about SARS-CoV-2 mutations

András Falus was born in 1947 in Budapest, Hungary and is a professor emeritus of Budapest’s Semmelweis University and a member of the Hungarian Academy of Sciences. His primary field of study is immunogenomics, allergy and onco-genomics. Most recently, his research has focused on histamine-related immunoregulation, non-coding DNA (e.g. microRNA) and microvesicles, a newly recognised ...

Coronavirus mutation vector background with disease molecules on blue. Medical research or pandemic virus prevention banner with COVID-19 abstract images under microscope. Europe coronavirus mutation

A scientist’s opinion: Interview with Dr Deepti Gurdasani about SARS-CoV-2 mutations

Dr Deepti Gurdasani ’s background is as a clinical epidemiologist and statistical geneticist. After completing her clinical training in internal medicine at Christian Medical College, Vellore, India, she completed her MPhil in epidemiology and biostatistics at the University of Cambridge in 2010, followed by a PhD examining genetic factors associated with disease in genetically diverse ...

Coronavirus mutation vector background with disease molecules on blue. Medical research or pandemic virus prevention banner with COVID-19 abstract images under microscope. Europe coronavirus mutation

SARS-CoV-2: the challenges of mutation and possible strategies

The efficacy of the current COVID-19 vaccines might be lower against the new variants of SARS-CoV-2. The new strain that emerged in the United Kingdom has a higher transmissibility than previous strains of the virus. We asked scientists whether the new mutations are a threat to the current public health measures and to COVID-19 vaccines.

Ampoules with Covid-19 vaccine on a laboratory bench to fight the coronavirus sars-cov-2 pandemic

A scientist’s opinion : Interview with Professor Johan Neyts about COVID-19 vaccines

Johan Neyts is full professor of virology at the University of Leuven, Belgium. He teaches virology at the medical school and at the school of dentistry. His lab is deeply involved in the development of antivirals against SARS-CoV-2. A second focus of the lab is the development of novel vaccine technologies. To that end, the yellow ...

Ampoules with Covid-19 vaccine on a laboratory bench to fight the coronavirus sars-cov-2 pandemic

A scientist’s opinion : Interview with Professor Earl Brown about COVID-19 vaccines

Professor Earl Brown is specialized in virology and microbiology. His main activities are on viral genetics and evolution, mainly directed at understanding how viruses cause disease (pathogenesis) or become adapted to new hosts; and the mechanism used by influenza virus to control the antiviral interferon response. He has experience with several viruses, including hepatitis C, ...

Ampoules with Covid-19 vaccine on a laboratory bench to fight the coronavirus sars-cov-2 pandemic

Covid-19: different types of vaccines and how they work

A range of Covid-19 vaccines are being developed worldwide and the differences between them can be confusing. How do the new mRNA vaccines work? What about vector vaccines? We asked scientists to give us an insight into the different types of Covid-19 vaccines.

injecting injection vaccine vaccination medicine flu woman doctor

A scientist’s opinion : Interview with Dr Kari Johansen about vaccine procedure

Dr Kari Johansen is expert in influenza and other respiratory viruses and vaccine-preventable diseases at the ECDC. She obtained her medical degree from the Karolinska Institute in Stockholm, where she also did her PhD (1999). Prior to joining the European Centre for Disease Prevention and Control (ECDC) in 2008, Dr Johansen worked for the Swedish ...

injecting injection vaccine vaccination medicine flu woman doctor

A scientist’s opinion : Interview with Marco Cavaleri about vaccine procedure

Marco Cavaleri is Head of Office, Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). He is also the chair of the COVID-19 EMA pandemic Task Force and is responsible for EMA activities regarding emerging pathogens, vaccines and antimicrobial resistance. He is a pharmacologist who has spent several years in industry in ...

injecting injection vaccine vaccination medicine flu woman doctor

COVID-19: ensuring a safe and effective vaccine

Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) for their thoughts.